ClinicalTrials.govpublic full text
Safety and Efficacy of TKI258 in Relapsed or Refractory Multiple Myeloma Patients, Who Are With or Without t(4;14) Chromosomal Translocation
relapsed or refractory multiple myeloma, multiple myeloma, relapsed, refractory, t(4;14), fgfr3, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 907887
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.